Application of deuterium depletion in combination with other conventional therapies inhibits lung cancer cell growth and migration; thus, it can help increase the survival time of non-small cell lung cancer patients.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer: about 84% of lung cancers are NSCLC. In advanced NSCLC, the median survival time is approximately 10-12 months. Hungary is a world leader in lung cancer deaths, with about 10,000–11,000 new lung cancer cases every year, writes Infostart. In a recent study published in the Journal of Cancer Research & Therapy, Hungarian scientists at HYD LLC. for Cancer Research and Drug Development, the University of Szeged and Avidin Ltd. revealed that a submolecular approach to tumour cell physiology could be the key to more effective cancer treatment. They analysed the effects of deuterium depletion on cancer cells, focusing on the median survival time of NSCLC patients.
The retrospective study involved 183 patients receiving conventional cancer treatment whose daily amount of fluid intake was replaced with deuterium-depleted water for at least 91 days. The experiments revealed that naturally occurring deuterium plays an important role in cell growth and deuterium depletion causes tumour regression.
The median survival time of the 183 patients showed a significant change compared to the usual 8−12 months: it was 149 months for 19 patients who started deuterium-depleted water consumption at an early stage and 40 months for 110 patients who began deuterium-depleted water consumption at an advanced stage.
Researchers also considered other factors; in addition to calculating the median survival time from the date of diagnosis and the start of deuterium-depleted water consumption, they compared the median survival time values of men and women.
The median survival time was six- and fivefold longer than in the case of average NSCLC patients: 61.9 months from diagnosis and 48.4 months from the start of deuterium-depleted water consumption.
As far as the gender differences are considered, the median survival time was markedly longer in the case of women (82 months) than in the case of men (33.2 months).
Source: infostart.hu, nobleresearch.org